WuXi AppTec
Latest statistics and disclosures from WuXi AppTec's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LYEL, ADAG, and represent 100.00% of WuXi AppTec's stock portfolio.
- Reduced shares in these 4 stocks: Ambrx Biopharma (-$14M), ADAG, PPBT, CSTL.
- Sold out of its positions in CSTL, Ambrx Biopharma, PPBT.
- WuXi AppTec was a net seller of stock by $-15M.
- WuXi AppTec has $29M in assets under management (AUM), dropping by -23.78%.
- Central Index Key (CIK): 0001832424
Tip: Access up to 7 years of quarterly data
Positions held by WuXi AppTec consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for WuXi AppTec
WuXi AppTec holds 2 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Lyell Immunopharma (LYEL) | 62.1 | $18M | 8.2M | 2.23 |
|
|
| Adagene Ads (ADAG) | 37.9 | $11M | -5% | 4.0M | 2.80 |
|
Past Filings by WuXi AppTec
SEC 13F filings are viewable for WuXi AppTec going back to 2023
- WuXi AppTec 2024 Q1 filed May 7, 2024
- WuXi AppTec 2023 Q4 filed Feb. 6, 2024